New tricks from an old oncogene

References

• Mitelman F, Johansson B, Mertens F. The impact of translocations and gene fusions on cancer causation. Nat Rev Cancer 2007; 7:233 - 245
   PubMed Web of Science ®Google Scholar
• Mitelman F, Johansson B, Mertens F. Mitelman Database of Chromosome Aberrations and Gene Fusions in Cancer: http://cgap.nci.nih.gov/Chromosomes/Mitelman 2010;
   Google Scholar
• Asp J, Persson F, Kost-Alimova M, Stenman G. CHCHD7-PLAG1 and TCEA1-PLAG1 gene fusions resulting from cryptic, intrachromosomal 8q rearrangements in pleomorphic salivary gland adenomas. Genes Chromosomes Cancer 2006; 45:820 - 828
   PubMed Web of Science ®Google Scholar
• Tomlins SA, Laxman B, Dhanasekaran SM, Helgeson BE, Cao X, Morris DS, et al. Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer. Nature 2007; 448:595 - 599
   PubMed Web of Science ®Google Scholar
• Soda M, Choi YL, Enomoto M, Takada S, Yamashita Y, Ishikawa S, et al. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature 2007; 448:561 - 566
   PubMed Web of Science ®Google Scholar
• Persson F, Winnes M, Andren Y, Wedell B, Dahlenfors R, Asp J, et al. High-resolution array CGH analysis of salivary gland tumors reveals fusion and amplification of the FGFR1 and PLAG1 genes in ring chromosomes. Oncogene 2008; 27:3072 - 3080
   PubMed Web of Science ®Google Scholar
• Persson F, Andren Y, Winnes M, Wedell B, Nordkvist A, Gudnadottir G, et al. High-resolution genomic profiling of adenomas and carcinomas of the salivary glands reveals amplification, rearrangement and fusion of HMGA2. Genes Chromosomes Cancer 2009; 48:69 - 82
   PubMed Web of Science ®Google Scholar
• Rikova K, Guo A, Zeng Q, Possemato A, Yu J, Haack H, et al. Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer. Cell 2007; 131:1190 - 1203
   PubMed Web of Science ®Google Scholar
• Stenman G. Fusion oncogenes and tumor type specificity—insights from salivary gland tumors. Semin Cancer Biol 2005; 15:224 - 235
   PubMed Web of Science ®Google Scholar
• Edwards PA. Fusion genes and chromosome translocations in the common epithelial cancers. J Pathol 2010; 220:244 - 254
   PubMed Web of Science ®Google Scholar
• Jhiang SM, Sagartz JE, Tong Q, Parker-Thornburg J, Capen CC, Cho JY, et al. Targeted expression of the ret/PTC1 oncogene induces papillary thyroid carcinomas. Endocrinology 1996; 137:375 - 378
   PubMed Web of Science ®Google Scholar
• Santoro M, Chiappetta G, Cerrato A, Salvatore D, Zhang L, Manzo G, et al. Development of thyroid papillary carcinomas secondary to tissue-specific expression of the RET/PTC1 oncogene in transgenic mice. Oncogene 1996; 12:1821 - 1826
   PubMed Web of Science ®Google Scholar
• Perez-Losada J, Pintado B, Gutierrez-Adan A, Flores T, Banares-Gonzalez B, del Campo JC, et al. The chimeric FUS/TLS-CHOP fusion protein specifically induces liposarcomas in transgenic mice. Oncogene 2000; 19:2413 - 2422
   PubMed Web of Science ®Google Scholar
• Haldar M, Hancock JD, Coffin CM, Lessnick SL, Capecchi MR. A conditional mouse model of synovial sarcoma: insights into a myogenic origin. Cancer Cell 2007; 11:375 - 388
   PubMed Web of Science ®Google Scholar
• Keller C, Arenkiel BR, Coffin CM, El-Bardeesy N, DePinho RA, Capecchi MR. Alveolar rhabdomyosarcomas in conditional Pax3:Fkhr mice: Cooperativity of Ink4a/ARF and Trp53 loss of function. Genes Dev 2004; 18:2614 - 2626
   PubMed Web of Science ®Google Scholar
• Li Z, Tognon CE, Godinho FJ, Yasaitis L, Hock H, Herschkowitz JI, et al. ETV6-NTRK3 fusion oncogene initiates breast cancer from committed mammary progenitors via activation of AP1 complex. Cancer Cell 2007; 12:542 - 558
   PubMed Web of Science ®Google Scholar
• Soda M, Takada S, Takeuchi K, Choi YL, Enomoto M, Ueno T, et al. A mouse model for EML4-ALK-positive lung cancer. Proc Natl Acad Sci USA 2008; 105:19893 - 19897
   PubMed Web of Science ®Google Scholar
• Carver BS, Tran J, Gopalan A, Chen Z, Shaikh S, Carracedo A, et al. Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate. Nat Genet 2009; 41:619 - 624
   PubMed Web of Science ®Google Scholar
• King JC, Xu J, Wongvipat J, Hieronymus H, Carver BS, Leung DH, et al. Cooperativity of TMPRSS2-ERG with PI3-kinase pathway activation in prostate oncogenesis. Nat Genet 2009; 41:524 - 526
   PubMed Web of Science ®Google Scholar
• Helman LJ, Meltzer P. Mechanisms of sarcoma development. Nat Rev Cancer 2003; 3:685 - 694
   PubMed Web of Science ®Google Scholar
• Dauphinot L, De Oliveira C, Melot T, Sevenet N, Thomas V, Weissman BE, et al. Analysis of the expression of cell cycle regulators in Ewing cell lines: EWS-FLI-1 modulates p57KIP2 and c-Myc expression. Oncogene 2001; 20:3258 - 3265
   PubMed Web of Science ®Google Scholar
• Matsumoto Y, Tanaka K, Nakatani F, Matsunobu T, Matsuda S, Iwamoto Y. Downregulation and forced expression of EWS-Fli1 fusion gene results in changes in the expression of G(1)regulatory genes. Br J Cancer 2001; 84:768 - 775
   PubMed Web of Science ®Google Scholar
• Li X, Tanaka K, Nakatani F, Matsunobu T, Sakimura R, Hanada M, et al. Transactivation of cyclin E gene by EWS-Fli1 and antitumor effects of cyclin dependent kinase inhibitor on Ewing's family tumor cells. Int J Cancer 2005; 116:385 - 394
   PubMed Web of Science ®Google Scholar
• Nakatani F, Tanaka K, Sakimura R, Matsumoto Y, Matsunobu T, Li X, et al. Identification of p21WAF1/CIP1 as a direct target of EWS-Fli1 oncogenic fusion protein. J Biol Chem 2003; 278:15105 - 15115
   PubMed Web of Science ®Google Scholar
• Sanchez G, Bittencourt D, Laud K, Barbier J, Delattre O, Auboeuf D, et al. Alteration of cyclin D1 transcript elongation by a mutated transcription factor upregulates the oncogenic D1b splice isoform in cancer. Proc Natl Acad Sci USA 2008; 105:6004 - 6009
   PubMed Web of Science ®Google Scholar
• Tognon C, Garnett M, Kenward E, Kay R, Morrison K, Sorensen PH. The chimeric protein tyrosine kinase ETV6-NTRK3 requires both Ras-Erk1/2 and PI3-kinase-Akt signaling for fibroblast transformation. Cancer Res 2001; 61:8909 - 8916
   PubMed Web of Science ®Google Scholar
• Xie Y, Skytting B, Nilsson G, Gasbarri A, Haslam K, Bartolazzi A, et al. SYT-SSX is critical for cyclin D1 expression in synovial sarcoma cells: A gain of function of the t(X;18)(p11.2;q11.2) translocation. Cancer Res 2002; 62:3861 - 3867
   PubMed Web of Science ®Google Scholar
• Cassinelli G, Favini E, Degl'Innocenti D, Salvi A, De Petro G, Pierotti MA, et al. RET/PTC1-driven neoplastic transformation and proinvasive phenotype of human thyrocytes involve Met induction and beta-catenin nuclear translocation. Neoplasia 2009; 11:10 - 21
   PubMed Web of Science ®Google Scholar
• Zhang L, Wang C. PAX3-FKHR transformation increases 26 S proteasome-dependent degradation of p27Kip1, a potential role for elevated Skp2 expression. J Biol Chem 2003; 278:27 - 36
   PubMed Web of Science ®Google Scholar
• Bento C, Andersson MK, Aman P. DDIT3/CHOP and the sarcoma fusion oncoprotein FUS-DDIT3/TLS-CHOP bind cyclin-dependent kinase 2. BMC Cell Biol 2009; 10:89
   PubMed Web of Science ®Google Scholar
• Shah JP, Ihde JK. Salivary gland tumors. Curr Probl Surg 1990; 27:775 - 883
   PubMed Web of Science ®Google Scholar
• Barnes L, Eveson JW, Reichart P, Sidransky D. World health organization classification of tumours. Pathology and genetics of head and neck tumours 2005; Lyon IARC Press 209 - 274
   Google Scholar
• Moller E, Stenman G, Mandahl N, Hamberg H, Molne L, van den Oord JJ, et al. POU5F1, encoding a key regulator of stem cell pluripotency, is fused to EWSR1 in hidradenoma of the skin and mucoepidermoid carcinoma of the salivary glands. J Pathol 2008; 215:78 - 86
   PubMed Web of Science ®Google Scholar
• Persson M, Andren Y, Mark J, Horlings HM, Persson F, Stenman G. Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck. Proc Natl Acad Sci USA 2009; 106:18740 - 18744
   PubMed Web of Science ®Google Scholar
• Kas K, Voz ML, Roijer E, Astrom AK, Meyen E, Stenman G, et al. Promoter swapping between the genes for a novel zinc finger protein and beta-catenin in pleiomorphic adenomas with t(3;8)(p21;q12) translocations. Nat Genet 1997; 15:170 - 174
   PubMed Web of Science ®Google Scholar
• Voz ML, Mathys J, Hensen K, Pendeville H, Van Valckenborgh I, Van Huffel C, et al. Microarray screening for target genes of the proto-oncogene PLAG1. Oncogene 2004; 23:179 - 191
   PubMed Web of Science ®Google Scholar
• Landrette SF, Kuo YH, Hensen K, Barjesteh van Waalwijk van Doorn-Khosrovani S, Perrat PN, Van de Ven WJ, et al. Plag1 and Plagl2 are oncogenes that induce acute myeloid leukemia in cooperation with Cbfb-MYH11. Blood 2005; 105:2900 - 2907
   PubMed Web of Science ®Google Scholar
• Ashar HR, Chouinard RA Jr, Dokur M, Chada K. In vivo modulation of HMGA2 expression. Biochim Biophys Acta 2010; 1799:55 - 61
   PubMed Web of Science ®Google Scholar
• Tessari MA, Gostissa M, Altamura S, Sgarra R, Rustighi A, Salvagno C, et al. Transcriptional activation of the cyclin A gene by the architectural transcription factor HMGA2. Mol Cell Biol 2003; 23:9104 - 9116
   PubMed Web of Science ®Google Scholar
• De Martino I, Visone R, Wierinckx A, Palmieri D, Ferraro A, Cappabianca P, et al. HMGA proteins upregulate CCNB2 gene in mouse and human pituitary adenomas. Cancer Res 2009; 69:1844 - 1850
   PubMed Web of Science ®Google Scholar
• Lee YS, Dutta A. The tumor suppressor micro-RNA let-7 represses the HMGA2 oncogene. Genes Dev 2007; 21:1025 - 1030
   PubMed Web of Science ®Google Scholar
• Mayr C, Hemann MT, Bartel DP. Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation. Science 2007; 315:1576 - 1579
   PubMed Web of Science ®Google Scholar
• Klemke M, Meyer A, Hashemi Nezhad M, Belge G, Bartnitzke S, Bullerdiek J. Loss of let-7 binding sites resulting from truncations of the 3′ untranslated region of HMGA2 mRNA in uterine leiomyomas. Cancer Genet Cytogenet 2010; 196:119 - 123
   PubMed Web of Science ®Google Scholar
• Tonon G, Modi S, Wu L, Kubo A, Coxon AB, Komiya T, et al. t(11;19)(q21;p13) translocation in mucoepidermoid carcinoma creates a novel fusion product that disrupts a Notch signaling pathway. Nat Genet 2003; 33:208 - 213
   PubMed Web of Science ®Google Scholar
• Enlund F, Behboudi A, Andren Y, Oberg C, Lendahl U, Mark J, et al. Altered Notch signaling resulting from expression of a WAMTP1-MAML2 gene fusion in mucoepidermoid carcinomas and benign Warthin's tumors. Exp Cell Res 2004; 292:21 - 28
   PubMed Web of Science ®Google Scholar
• Behboudi A, Enlund F, Winnes M, Andren Y, Nordkvist A, Leivo I, et al. Molecular classification of mucoepidermoid carcinomas-prognostic significance of the MECT1-MAML2 fusion oncogene. Genes Chromosomes Cancer 2006; 45:470 - 481
   PubMed Web of Science ®Google Scholar
• Lin SE, Oyama T, Nagase T, Harigaya K, Kitagawa M. Identification of new human mastermind proteins defines a family that consists of positive regulators for notch signaling. J Biol Chem 2002; 277:50612 - 50620
   PubMed Web of Science ®Google Scholar
• Wu L, Sun T, Kobayashi K, Gao P, Griffin JD. Identification of a family of mastermind-like transcriptional coactivators for mammalian notch receptors. Mol Cell Biol 2002; 22:7688 - 7700
   PubMed Web of Science ®Google Scholar
• Conkright MD, Canettieri G, Screaton R, Guzman E, Miraglia L, Hogenesch JB, et al. TORCs: Transducers of regulated CREB activity. Mol Cell 2003; 12:413 - 423
   PubMed Web of Science ®Google Scholar
• Iourgenko V, Zhang W, Mickanin C, Daly I, Jiang C, Hexham JM, et al. Identification of a family of cAMP response element-binding protein coactivators by genome-scale functional analysis in mammalian cells. Proc Natl Acad Sci USA 2003; 100:12147 - 12152
   PubMed Web of Science ®Google Scholar
• Coxon A, Rozenblum E, Park YS, Joshi N, Tsurutani J, Dennis PA, et al. Mect1-Maml2 fusion oncogene linked to the aberrant activation of cyclic AMP/CREB regulated genes. Cancer Res 2005; 65:7137 - 7144
   PubMed Web of Science ®Google Scholar
• Wu L, Liu J, Gao P, Nakamura M, Cao Y, Shen H, et al. Transforming activity of MECT1-MAML2 fusion oncoprotein is mediated by constitutive CREB activation. EMBO J 2005; 24:2391 - 2402
   PubMed Web of Science ®Google Scholar
• Fehr A, Roser K, Belge G, Loning T, Bullerdiek J. A closer look at Warthin tumors and the t(11;19). Cancer Genet Cytogenet 2008; 180:135 - 139
   PubMed Web of Science ®Google Scholar
• Winnes M, Molne L, Suurkula M, Andren Y, Persson F, Enlund F, et al. Frequent fusion of the CRTC1 and MAML2 genes in clear cell variants of cutaneous hidradenomas. Genes Chromosomes Cancer 2007; 46:559 - 563
   PubMed Web of Science ®Google Scholar
• Skalova A, Vanecek T, Sima R, Laco J, Weinreb I, Perez-Ordonez B, et al. Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity. Am J Surg Pathol 2010; 34:599 - 608
   PubMed Web of Science ®Google Scholar
• Duesberg PH, Bister K, Moscovici C. Genetic structure of avian myeloblastosis virus, released from transformed myeloblasts as a defective virus particle. Proc Natl Acad Sci USA 1980; 77:5120 - 5124
   PubMed Web of Science ®Google Scholar
• Souza LM, Strommer JN, Hillyard RL, Komaromy MC, Baluda MA. Cellular sequences are present in the presumptive avian myeloblastosis virus genome. Proc Natl Acad Sci USA 1980; 77:5177 - 5181
   PubMed Web of Science ®Google Scholar
• Baluda MA, Reddy EP. Anatomy of an integrated avian myeloblastosis provirus: structure and function. Oncogene 1994; 9:2761 - 2774
   PubMed Web of Science ®Google Scholar
• Lipsick JS, Wang DM. Transformation by v-Myb. Oncogene 1999; 18:3047 - 3055
   PubMed Web of Science ®Google Scholar
• Clappier E, Cuccuini W, Kalota A, Crinquette A, Cayuela JM, Dik WA, et al. The C-MYB locus is involved in chromosomal translocation and genomic duplications in human T-cell acute leukemia (T-ALL), the translocation defining a new T-ALL subtype in very young children. Blood 2007; 110:1251 - 1261
   PubMed Web of Science ®Google Scholar
• Oh IH, Reddy EP. The myb gene family in cell growth, differentiation and apoptosis. Oncogene 1999; 18:3017 - 3033
   PubMed Web of Science ®Google Scholar
• Ramsay RG, Gonda TJ. MYB function in normal and cancer cells. Nat Rev Cancer 2008; 8:523 - 534
   PubMed Web of Science ®Google Scholar
• Dash AB, Orrico FC, Ness SA. The EVES motif mediates both intermolecular and intramolecular regulation of c-Myb. Genes Dev 1996; 10:1858 - 1869
   PubMed Web of Science ®Google Scholar
• Molvaersmyr AK, Saether T, Gilfillan S, Lorenzo PI, Kvaloy H, Matre V, et al. A SUMO-regulated activation function controls synergy of c-Myb through a repressor-activator switch leading to differential p300 recruitment. Nucleic Acids Res 2010; 38:4970 - 4984
   PubMed Web of Science ®Google Scholar
• Mucenski ML, McLain K, Kier AB, Swerdlow SH, Schreiner CM, Miller TA, et al. A functional c-myb gene is required for normal murine fetal hepatic hematopoiesis. Cell 1991; 65:677 - 689
   PubMed Web of Science ®Google Scholar
• Lieu YK, Reddy EP. Conditional c-myb knockout in adult hematopoietic stem cells leads to loss of self-renewal due to impaired proliferation and accelerated differentiation. Proc Natl Acad Sci USA 2009; 106:21689 - 21694
   PubMed Web of Science ®Google Scholar
• Lahortiga I, De Keersmaecker K, Van Vlierberghe P, Graux C, Cauwelier B, Lambert F, et al. Duplication of the MYB oncogene in T cell acute lymphoblastic leukemia. Nat Genet 2007; 39:593 - 595
   PubMed Web of Science ®Google Scholar
• Stenman G, Sandros J, Dahlenfors R, Juberg-Ode M, Mark J. 6q- and loss of the Y chromosome—two common deviations in malignant human salivary gland tumors. Cancer Genet Cytogenet 1986; 22:283 - 293
   PubMed Web of Science ®Google Scholar
• Nordkvist A, Mark J, Gustafsson H, Bang G, Stenman G. Non-random chromosome rearrangements in adenoid cystic carcinoma of the salivary glands. Genes Chromosomes Cancer 1994; 10:115 - 121
   PubMed Web of Science ®Google Scholar
• Stenman G, Delorme EO, Lau CC, Sager R. Transfection with plasmid pSV2gptEJ induces chromosome rearrangements in CHEF cells. Proc Natl Acad Sci USA 1987; 84:184 - 188
   PubMed Web of Science ®Google Scholar
• Xiao C, Calado DP, Galler G, Thai TH, Patterson HC, Wang J, et al. MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb. Cell 2007; 131:146 - 159
   PubMed Web of Science ®Google Scholar
• Barroga CF, Pham H, Kaushansky K. Thrombopoietin regulates c-Myb expression by modulating micro RNA 150 expression. Exp Hematol 2008; 36:1585 - 1592
   PubMed Web of Science ®Google Scholar
• Lin YC, Kuo MW, Yu J, Kuo HH, Lin RJ, Lo WL, et al. c-Myb is an evolutionary conserved miR-150 target and miR-150/c-Myb interaction is important for embryonic development. Mol Biol Evol 2008; 25:2189 - 2198
   PubMed Web of Science ®Google Scholar
• Tan LP, Wang M, Robertus JL, Schakel RN, Gibcus JH, Diepstra A, et al. miRNA profiling of B-cell subsets: specific miRNA profile for germinal center B cells with variation between centroblasts and centrocytes. Lab Invest 2009; 89:708 - 716
   PubMed Web of Science ®Google Scholar
• Venugopal SK, Jiang J, Kim TH, Li Y, Wang SS, Torok NJ, et al. Liver fibrosis causes downregulation of miRNA-150 and miRNA-194 in hepatic stellate cells and their overexpression causes decreased stellate cell activation. Am J Physiol Gastrointest Liver Physiol 2009; 298:G101 - G106
   PubMed Web of Science ®Google Scholar
• Chung EY, Dews M, Cozma D, Yu D, Wentzel EA, Chang TC, et al. c-Myb oncoprotein is an essential target of the dleu2 tumor suppressor microRNA cluster. Cancer Biol Ther 2008; 7:1758 - 1764
   PubMed Web of Science ®Google Scholar
• Navarro F, Gutman D, Meire E, Caceres M, Rigoutsos I, Bentwich Z, et al. miR-34a contributes to megakaryocytic differentiation of K562 cells independently of p53. Blood 2009; 114:2181 - 2192
   PubMed Web of Science ®Google Scholar
• Zhao H, Kalota A, Jin S, Gewirtz AM. The c-myb proto-oncogene and microRNA-15a comprise an active autoregulatory feedback loop in human hematopoietic cells. Blood 2009; 113:505 - 516
   PubMed Web of Science ®Google Scholar
• Sakura H, Kanei-Ishii C, Nagase T, Nakagoshi H, Gonda TJ, Ishii S. Delineation of three functional domains of the transcriptional activator encoded by the c-myb protooncogene. Proc Natl Acad Sci USA 1989; 86:5758 - 5762
   PubMed Web of Science ®Google Scholar
• Dubendorff JW, Whittaker LJ, Eltman JT, Lipsick JS. Carboxy-terminal elements of c-Myb negatively regulate transcriptional activation in cis and in trans. Genes Dev 1992; 6:2524 - 2535
   PubMed Web of Science ®Google Scholar
• Press RD, Reddy EP, Ewert DL. Overexpression of C-terminally but not N-terminally truncated Myb induces fibrosarcomas: a novel nonhematopoietic target cell for the myb oncogene. Mol Cell Biol 1994; 14:2278 - 2290
   PubMed Web of Science ®Google Scholar
• Geurts JM, Schoenmakers EF, Roijer E, Astrom AK, Stenman G, van de Ven WJ. Identification of NFIB as recurrent translocation partner gene of HMGIC in pleomorphic adenomas. Oncogene 1998; 16:865 - 872
   PubMed Web of Science ®Google Scholar
• O'Neil J, Tchinda J, Gutierrez A, Moreau L, Maser RS, Wong KK, et al. Alu elements mediate MYB gene tandem duplication in human T-ALL. J Exp Med 2007; 204:3059 - 3066
   PubMed Web of Science ®Google Scholar
• Kauraniemi P, Hedenfalk I, Persson K, Duggan DJ, Tanner M, Johannsson O, et al. MYB oncogene amplification in hereditary BRCA1 breast cancer. Cancer Res 2000; 60:5323 - 5328
   PubMed Web of Science ®Google Scholar
• Wallrapp C, Muller-Pillasch F, Solinas-Toldo S, Lichter P, Friess H, Buchler M, et al. Characterization of a high copy number amplification at 6q24 in pancreatic cancer identifies c-myb as a candidate oncogene. Cancer Res 1997; 57:3135 - 3139
   PubMed Web of Science ®Google Scholar
• Alitalo K, Winqvist R, Lin CC, de la Chapelle A, Schwab M, Bishop JM. Aberrant expression of an amplified c-myb oncogene in two cell lines from a colon carcinoma. Proc Natl Acad Sci USA 1984; 81:4534 - 4538
   PubMed Web of Science ®Google Scholar
• Welter C, Henn W, Theisinger B, Fischer H, Zang KD, Blin N. The cellular myb oncogene is amplified, rearranged and activated in human glioblastoma cell lines. Cancer Lett 1990; 52:57 - 62
   PubMed Web of Science ®Google Scholar
• Maher CA, Kumar-Sinha C, Cao X, Kalyana-Sundaram S, Han B, Jing X, et al. Transcriptome sequencing to detect gene fusions in cancer. Nature 2009; 458:97 - 101
   PubMed Web of Science ®Google Scholar
• Maher CA, Palanisamy N, Brenner JC, Cao X, Kalyana-Sundaram S, Luo S, et al. Chimeric transcript discovery by paired-end transcriptome sequencing. Proc Natl Acad Sci USA 2009; 106:12353 - 12358
   PubMed Web of Science ®Google Scholar
• Phuchareon J, Ohta Y, Woo JM, Eisele DW, Tetsu O. Genetic profiling reveals cross-contamination and misidentification of 6 adenoid cystic carcinoma cell lines: ACC2, ACC3, ACCM, ACCNS, ACCS and CAC2. PLoS One 2009; 4:6040
   Web of Science ®Google Scholar
• Laxman B, Tomlins SA, Mehra R, Morris DS, Wang L, Helgeson BE, et al. Noninvasive detection of TMPRSS2:ERG fusion transcripts in the urine of men with prostate cancer. Neoplasia 2006; 8:885 - 888
   PubMed Web of Science ®Google Scholar
• Rice KR, Chen Y, Ali A, Whitman EJ, Blase A, Ibrahim M, et al. Evaluation of the ETS-related gene mRNA in urine for the detection of prostate cancer. Clin Cancer Res 2010; 16:1572 - 1576
   PubMed Web of Science ®Google Scholar
• Spiro RH. Salivary neoplasms: overview of a 35-year experience with 2,807 patients. Head Neck Surg 1986; 8:177 - 184
   PubMedGoogle Scholar
• Williams BB, Wall M, Miao RY, Williams B, Bertoncello I, Kershaw MH, et al. Induction of T cell-mediated immunity using a c-Myb DNA vaccine in a mouse model of colon cancer. Cancer Immunol Immunother 2008; 57:1635 - 1645
   PubMed Web of Science ®Google Scholar
• Gewirtz AM. Myb targeted therapeutics for the treatment of human malignancies. Oncogene 1999; 18:3056 - 3062
   PubMed Web of Science ®Google Scholar
• Presta LG, Chen H, O'Connor SJ, Chisholm V, Meng YG, Krummen L, et al. Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders. Cancer Res 1997; 57:4593 - 4599
   PubMed Web of Science ®Google Scholar
• Ivy SP, Wick JY, Kaufman BM. An overview of small-molecule inhibitors of VEGFR signaling. Nat Rev Clin Oncol 2009; 6:569 - 579
   PubMed Web of Science ®Google Scholar
• Vogler M, Dinsdale D, Dyer MJ, Cohen GM. Bcl-2 inhibitors: small molecules with a big impact on cancer therapy. Cell Death Differ 2009; 16:360 - 367
   PubMed Web of Science ®Google Scholar
• Bansal R, Magge S, Winkler S. Specific inhibitor of FGF receptor signaling: FGF-2-mediated effects on proliferation, differentiation and MAPK activation are inhibited by PD173074 in oligodendrocyte-lineage cells. J Neurosci Res 2003; 74:486 - 493
   PubMed Web of Science ®Google Scholar
• Pardo OE, Latigo J, Jeffery RE, Nye E, Poulsom R, Spencer-Dene B, et al. The fibroblast growth factor receptor inhibitor PD173074 blocks small cell lung cancer growth in vitro and in vivo. Cancer Res 2009; 69:8645 - 8651
   PubMed Web of Science ®Google Scholar
• Prystowsky MB, Adomako A, Smith RV, Kawachi N, McKimpson W, Atadja P, et al. The histone deacetylase inhibitor LBH589 inhibits expression of mitotic genes causing G2/M arrest and cell death in head and neck squamous cell carcinoma cell lines. J Pathol 2009; 218:467 - 477
   PubMed Web of Science ®Google Scholar
• Ishikawa C, Tafuku S, Kadekaru T, Sawada S, Tomita M, Okudaira T, et al. Anti-adult T-cell leukemia effects of brown algae fucoxanthin and its deacetylated product, fucoxanthinol. Int J Cancer 2008; 123:2702 - 2712
   PubMed Web of Science ®Google Scholar
• Hotte SJ, Winquist EW, Lamont E, MacKenzie M, Vokes E, Chen EX, et al. Imatinib mesylate in patients with adenoid cystic cancers of the salivary glands expressing c-kit: a Princess Margaret Hospital phase II consortium study. J Clin Oncol 2005; 23:585 - 590
   PubMed Web of Science ®Google Scholar
• Pfeffer MR, Talmi Y, Catane R, Symon Z, Yosepovitch A, Levitt M. A phase II study of Imatinib for advanced adenoid cystic carcinoma of head and neck salivary glands. Oral Oncol 2007; 43:33 - 36
   PubMed Web of Science ®Google Scholar